Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease

Konstantinos Papamichael, Niels Vande Casteele, Bincy P. Abraham, Timothy Ritter, Anjali Jain, Adam S. Cheifetz

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Clinical Gastroenterology and Hepatology
Early online date	Nov 1 2022
DOIs	https://doi.org/10.1016/j.cgh.2022.10.037
State	Published - Jan 2023

Access to Document

@article{a3a85656629748de9f522ee44665b8b8,

title = "Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease",

author = "Konstantinos Papamichael and {Vande Casteele}, Niels and Abraham, {Bincy P.} and Timothy Ritter and Anjali Jain and Cheifetz, {Adam S.}",

year = "2023",

month = jan,

doi = "10.1016/j.cgh.2022.10.037",

language = "English (US)",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease

AU - Papamichael, Konstantinos

AU - Vande Casteele, Niels

AU - Abraham, Bincy P.

AU - Ritter, Timothy

AU - Jain, Anjali

AU - Cheifetz, Adam S.

PY - 2023/1

Y1 - 2023/1

U2 - 10.1016/j.cgh.2022.10.037

DO - 10.1016/j.cgh.2022.10.037

M3 - Article

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

ER -